Reuters logo
BRIEF-Intellipharmaceutics submits new drug application for Rexista
2016年11月25日 / 下午12点52分 / 10 个月前

BRIEF-Intellipharmaceutics submits new drug application for Rexista

Nov 25 (Reuters) - Intellipharmaceutics International Inc

* Intellipharmaceutics submits new drug application for Rexista (oxycodone hydrochloride extended release), an abuse deterrent opioid analgesic for the treatment of moderate to severe pain

* Intellipharmaceutics International - Has identified potential manufacturing partners; currently evaluating manufacturing options for Rexista in U.S. Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below